|
Items in cart [0] |
Questions? Call 888-624-8373 |
| Copyright © 2009. National Academy of Sciences. All rights reserved. Terms of Use and Privacy Statement |
Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 111
Appendix C
Thimerosal Content in
Licensed Vaccines
(Adapted from FDA, 2001, AAP, 1999)
OCR for page 112
OCR for page 113
Ad
~ -
A)
v:
a:
o
~ -
N
As
i_
o
o
-
V
o
C)
-
~:
o
V,
S:
·_
C)
V
-
Em
~ 1~
e:^ ~
~= ~=
~~)~ 555
E
e
o-5 =
it= _
s ·,O
~ =
-
o,
a
Cal
3
_
'_
U.
3
~0
-
¢,, 1~, ~ =, 3
~ O ~ ~
~ O ~ ~
O _ _
o Z Z
to
V
O
—O——
O O O
0 00
Ct
O
C) ~ 'C)
X ~ Ct
3 ~ ~ ~
.~ U.,
~ X ~ ~
c: 3 z
E
.= X ~
=, ~
o
o
rs
U)
m
.=
~ ~ ~ ~ ~ ~ D
: - ~ ~ ~ i'8 ~ ~o
O O O ~ <1
_
Z Z
O 00 ~ ~0
7
O O O O
O
O. O. .
O O
3 ~ ~
~ << ~
U. , U.
_ ~ '_
~ C,) ~ C)
<: 3 <~
..
~ ~ e ~ :~ ~ e, :: 0
Q41
=~3
2'
~ 3
~ ~ ~ ~g
_
C
C~
4,
._
o
qe,
oo
o
Z
~ C
=~!
OCR for page 114
~
o
v
~
o
o
o
o
v
-
-
£
x ~
Ct Cat
? -
2 X 2
C C~ C
E
A, ~ m ~
~ :=
a_
0 0
z
<,^
no ;.
Ceder
O
O ~
~ US
~ O
-
~S
o
·E
s
._
o
V
z
Cal
s
·C~
o
s
·_
s
V
a
a
·
;^
L4
V
of 0 0
0 0 0 0
of 0 0
of 0 0
~O
U. U3
== ~ ~
X _ X
~ ~ e ~ :E
S
::
o
.~
._
-
8
s
-
v
I:
C)
C,
~:
L.
- ~
v
s
o
- -
o
z
~a
· -
~z
o.
o
Q)
-
.-
~3
3
° CC
s~
b0
o
O
Z ~
o
Pa
=
~:
*
~ ~ 3 ~
U.
·E
o
Ct
o
~D
C,
-
c)
Ct
s
C)
*
~ -6] 18 ~ ~
U.,
6
o
o
U.
w
;^
c
c
o
>`
o
-
~C
C~
.
C,
c
ec
:>
U.
c
:C
oo
V~
-
~ o
o o
,, ~o
.
_ {C
-
_ _
o,
o ~
.= .=
o t
~ Q ~
W
. o oo
~,. ~ o
3 ~ °
^e .U'
~W7 ~ °
,
o
~ ~ C)
= ~ ~ ~ 6 .
C ~ ~ 4,, _
0 ·° ' ~ c =0
O ~ - - ~ ~ _
C E ~ ~ ,..=
at < 2 ~ Z
~ ~ . ~ ~ Z
OCR for page 115
115
IMMUNIZE TION SAFETYREVIEW
TABLE C-2 Currently Licensed Vaccines That Are Recommended for Some
Children
Current Thimerosal Content
(June 2001)
Vaccine Brand Name Manufacturer % Thim Cone Hg ~g/05mL
DT All Products Lederle 0.01 25
(Dipithe asthma
toxoid)
TT All Products Lederle 0.01 25
(Tedious Toxoid)
Hepatitis A Havrix A SmithKline Beecham 0 0
Vaqta Merck 0 0
Influenza All Aventis Pasteur, 0.01 25
Medeva, and
Led erl e- Wyeth
NOTE: The formulation of vaccines listed in C-2 and C-3 have not changed since August/September
1999.
TABLE C-3 Over Licensed Vaccines in the United States
Current Thimerosal
Content (June 2001)
Vaccine Brand Name Manufacturer % Thim Cone Hg ~g/0~5mL
Anthrax Anthrax BioPort Corporation 0 0
Vaccine
BCG N/A N/A
. .
Hepatitis A- Twinrix Glaxo-SmithKline 0 0
Hepatitis B
Hepatitis B Engerix B Glaxo-SmithKline 0.00S 12.5
(~/tfonn~Jotion)
Recombivax Merck 0.005 12.5
HE
(it fo~lat~on)
Lyme LYMErix Glaxo-SmithKline 0 0
Meltings Menomune A, Aventis Pasteur 0.01 25
coccal6 C, AC and
A/C/YM[-1 35
Rabies MOVAX Aventis Pasteur 0 0
Rabavert Chiron 0 0
Rabies Vaccine Bioport Corporation N/A N/A
Adsorbed7
Typhoid Typhim Vi Aventis Pasteur 0 0
Fever
Typhoid Ty21a V~votefBema 0 0
Typhoid Vac- Wyeth-Ayerst 0 0
cine
Yellow Y-F-Vax Aventis Pasteur 0 0
Fever
6 Menomunc AJC/YIW-135, a thimerosal-containing vaccine, is not indicated for infants and children younger teal? 2 yews of
age except as short-tenn protection of infants 3 months and older against Group ~ (Physician 's Desk Reference, 2001).
' This vaccine is no longa available but did contain 0.01% thimerosal ( 25 fig Hg/O.SmL).
N/A means that the product is no longer currently produced or distributed in We United States.
OCR for page 116
Representative terms from entire chapter:
licensed vaccines
